DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 55 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $138,000 | -94.9% | 2,217 | -98.1% | 0.00% | -88.9% |
| Q1 2019 | $2,680,000 | +9141.4% | 115,428 | +8150.8% | 0.01% | – |
| Q4 2018 | $29,000 | -92.8% | 1,399 | -93.0% | 0.00% | -100.0% |
| Q1 2018 | $403,000 | -58.0% | 20,087 | -52.5% | 0.00% | -60.0% |
| Q4 2017 | $959,000 | +84.8% | 42,313 | +54.8% | 0.01% | +66.7% |
| Q3 2017 | $519,000 | – | 27,337 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $15,385,743 | 19.76% |
| Redmile Group, LLC | 4,475,384 | $56,926,884 | 2.71% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,897,606 | $87,737,548 | 1.93% |
| Parkman Healthcare Partners LLC | 597,403 | $7,598,966 | 1.39% |
| Ghost Tree Capital, LLC | 325,000 | $4,134,000 | 1.36% |
| BRAIDWELL LP | 3,336,221 | $42,436,731 | 1.34% |
| AlphaCentric Advisors LLC | 132,000 | $1,679,040 | 0.95% |
| ARMISTICE CAPITAL, LLC | 4,612,000 | $58,664,640 | 0.90% |
| Sunesis Advisors, LLC | 96,299 | $1,224,923 | 0.87% |
| EcoR1 Capital, LLC | 993,000 | $12,630,960 | 0.43% |